Truvada was also the overall highest-selling drug on the market for the treatment of HIV in 2006, with sales of approximately US$1.2 billion worldwide 1. The first cross-class combination NRTI ...

who discovered HIV in 1983. Their discovery of the virus led to the development of antiretroviral therapy, a combination of drugs that stop the virus from making more copies of itself and ...

The 90-day definition of combo therapy might have overlooked serious adverse events leading to early discontinuation. The median follow-up duration of 15 months was likely insufficient to assess ...

First-in-human study evaluating a novel long-acting injectable antiretroviral therapy provides promising early results on its ...

Taimed Biologics Inc.’s TMB-365/TMB-380 long-acting combination of broadly neutralizing antibodies (bnAbs) regimen for HIV ...

Gilead looks set to file its new single tablet HIV regimen, a combination which could prove ... Gilead said BIC/F/TAF met the definition of non-inferiority in all four studies, with comparable ...